These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11690547)

  • 1. Gene therapy for bladder cancer using adenoviral vector.
    Wada Y; Gotoh A; Shirakawa T; Hamada K; Kamidono S
    Mol Urol; 2001; 5(2):47-52. PubMed ID: 11690547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.
    Miyake H; Yamanaka K; Muramaki M; Hara I; Gleave ME
    Neoplasia; 2005 Feb; 7(2):171-9. PubMed ID: 15802022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer.
    Eastham JA; Hall SJ; Sehgal I; Wang J; Timme TL; Yang G; Connell-Crowley L; Elledge SJ; Zhang WW; Harper JW
    Cancer Res; 1995 Nov; 55(22):5151-5. PubMed ID: 7585563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated P53 gene transfer in human bladder cancer model.
    Miyake H; Hara I; Hara S; Arakawa S; Kamidono S
    Urology; 2000 Aug; 56(2):332-6. PubMed ID: 10925118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy.
    Pagliaro LC; Keyhani A; Williams D; Woods D; Liu B; Perrotte P; Slaton JW; Merritt JA; Grossman HB; Dinney CP
    J Clin Oncol; 2003 Jun; 21(12):2247-53. PubMed ID: 12805322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer.
    Hamada K; Alemany R; Zhang WW; Hittelman WN; Lotan R; Roth JA; Mitchell MF
    Cancer Res; 1996 Jul; 56(13):3047-54. PubMed ID: 8674061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer.
    Miyake H; Hanada N; Nakamura H; Kagawa S; Fujiwara T; Hara I; Eto H; Gohji K; Arakawa S; Kamidono S; Saya H
    Oncogene; 1998 Feb; 16(7):933-43. PubMed ID: 9484785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.
    Liu TJ; Zhang WW; Taylor DL; Roth JA; Goepfert H; Clayman GL
    Cancer Res; 1994 Jul; 54(14):3662-7. PubMed ID: 8033080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
    Parker LP; Wolf JK; Price JE
    Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo recombinant adenovirus-mediated p53 gene therapy in a syngeneic rat model for colorectal cancer.
    Baek JH; Agarwal ML; Tubbs RR; Vladisavljevic A; Tomita H; Bukowski RM; Milsom JW; Kim JM; Kwak JY
    J Korean Med Sci; 2004 Dec; 19(6):834-41. PubMed ID: 15608394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 Mutation in bladder cancer patients in Japan and inhibition of growth by in vitro adenovirus-mediated wild-type p53 transduction in bladder cancer cells.
    Irie A; Uchida T; Ishida H; Matsumoto K; Iwamura M; Baba S
    Mol Urol; 2001; 5(2):53-8. PubMed ID: 11690548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical study of adenoviral p53 gene therapy for esophageal cancer.
    Shimada H; Shimizu T; Ochiai T; Liu TL; Sashiyama H; Nakamura A; Matsubara H; Gunji Y; Kobayashi S; Tagawa M; Sakiyama S; Hiwasa T
    Surg Today; 2001; 31(7):597-604. PubMed ID: 11495154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic effects of recombinant adenovirus p53 and cell cycle regulator genes (p21 WAF1/CIP1 and p16CDKN4) in human prostate cancers.
    Gotoh A; Kao C; Ko SC; Hamada K; Liu TJ; Chung LW
    J Urol; 1997 Aug; 158(2):636-41. PubMed ID: 9224383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for bladder cancer.
    Pagliaro LC
    World J Urol; 2000 Apr; 18(2):148-51. PubMed ID: 10854151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin.
    Pagliaro LC; Keyhani A; Liu B; Perrotte P; Wilson D; Dinney CP
    Urol Oncol; 2003; 21(6):456-62. PubMed ID: 14693272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell line.
    Qi V; Weinrib L; Ma N; Li JH; Klamut H; Liu FF
    Int J Hyperthermia; 2001; 17(1):38-47. PubMed ID: 11212879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.
    Weinrib L; Li JH; Donovan J; Huang D; Liu FF
    Cancer Gene Ther; 2001 May; 8(5):352-60. PubMed ID: 11477455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
    Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
    Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
    Liu TJ; el-Naggar AK; McDonnell TJ; Steck KD; Wang M; Taylor DL; Clayman GL
    Cancer Res; 1995 Jul; 55(14):3117-22. PubMed ID: 7606733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer model.
    Yamanaka K; Gleave ME; Hara I; Muramaki M; Miyake H
    Mol Cancer Ther; 2005 Feb; 4(2):187-95. PubMed ID: 15713890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.